Items where Author is "Allahyari, A."
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.
Article
(2022) Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer. p. 10.
(2020) Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial. Clinical Therapeutics. pp. 848-859. ISSN 0149-2918
(2015) Medical Oncology, History and Its Future in Iran. Archives of Iranian Medicine. pp. 799-805. ISSN 1029-2977